During the same period of 2024-25, the health insurance company will spend Rs. 206 crore net profit was earned.
During the quarter the total revenue of the company increased to Rs. 2,078 crore which in the corresponding period of the previous year was Rs. 1,565 crore, Niva Bupa Health Insurance said in a regulatory filing.
During this period the total expenditure rose to Rs. 1,795 crore as compared to Rs. 1,470 crores.
During the quarter under review, gross written premium increased to Rs. 2,880 crore as compared to Rs. 2,079 crores.
Live events
However, the solvency ratio declined to 2.49 as on March 31, 2026 from 3.03 at the end of the fourth quarter of the previous fiscal.
It further stated that the Board has approved the promotion of Ankur Kharbanda (presently appointed and appointed as Executive Director and Chief Business Officer) to the post of Executive Director and Deputy Chief Executive Officer based on the recommendation of the Nomination and Remuneration Committee.
Reflecting its focus on customer service and claims experience, the company reported a claim settlement ratio of 94.4 per cent for FY26, an improvement of 205 basis points over the previous year, Niva Bupa said in a statement.
The company continued to strengthen its position in the retail health segment, improving market share to 10.1 per cent at the end of FY26, representing an increase of 76 basis points over FY25, it said.
Krishnan Ramachandran, MD and CEO of the company, said, “Our market share gains and improvement in claim settlement ratio reflect the trust customers have in us and our continued focus on delivering superior health insurance experiences.” PTI
(You can now subscribe to our ETMarkets WhatsApp channel)